Andrew Tatham, Heidelberg Engineering (F);
Peter Rosen, None;
Erwin Boer, None;
Linda Zangwill, Carl Zeiss Meditec (F), Heidelberg Engineering GmbH (F), Nidek (F), Optovue (F), Topcon (F);
Robert Weinreb, Aerie (F), Alcon (C), Allergan (C), Bausch&Lomb (C), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Genentech (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Nidek (F), Novartis (F), Optovue (F), Sensimed (C), Topcon (C), Topcon (F);
Daniel Meira-Freitas, None;
Mauro Della Penna, None;
Felipe Medeiros, Alcon Laboratories (F), Alcon Laboratories (R), Allergan (C), Allergan (F), Allergan (R), Bausch & Lomb (F), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec (R), Heidelberg Engineering GmbH (F), Merck (F), National Eye Institute (F), Novartis (C), Reichert (F), Reichert (R), Sensimed (F), Topcon (F)